Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults

JAMA. 2008 Sep 17;300(11):1303-10. doi: 10.1001/jama.300.11.1303. Epub 2008 Sep 16.

Abstract

Context: Bisphenol A (BPA) is widely used in epoxy resins lining food and beverage containers. Evidence of effects in animals has generated concern over low-level chronic exposures in humans.

Objective: To examine associations between urinary BPA concentrations and adult health status.

Design, setting, and participants: Cross-sectional analysis of BPA concentrations and health status in the general adult population of the United States, using data from the National Health and Nutrition Examination Survey 2003-2004. Participants were 1455 adults aged 18 through 74 years with measured urinary BPA and urine creatinine concentrations. Regression models were adjusted for age, sex, race/ethnicity, education, income, smoking, body mass index, waist circumference, and urinary creatinine concentration. The sample provided 80% power to detect unadjusted odds ratios (ORs) of 1.4 for diagnoses of 5% prevalence per 1-SD change in BPA concentration, or standardized regression coefficients of 0.075 for liver enzyme concentrations, at a significance level of P < .05.

Main outcome measures: Chronic disease diagnoses plus blood markers of liver function, glucose homeostasis, inflammation, and lipid changes.

Results: Higher urinary BPA concentrations were associated with cardiovascular diagnoses in age-, sex-, and fully adjusted models (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.18-1.63; P = .001 with full adjustment). Higher BPA concentrations were also associated with diabetes (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.21-1.60; P < .001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes gamma-glutamyltransferase (OR per 1-SD increase in BPA concentration, 1.29; 95% CI, 1.14-1.46; P < .001) and alkaline phosphatase (OR per 1-SD increase in BPA concentration, 1.48; 95% CI, 1.18-1.85; P = .002).

Conclusion: Higher BPA exposure, reflected in higher urinary concentrations of BPA, may be associated with avoidable morbidity in the community-dwelling adult population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Benzhydryl Compounds
  • Biomarkers / blood
  • Biomarkers / urine*
  • Blood Glucose
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / urine
  • Chronic Disease
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Diabetes Mellitus, Type 2 / urine
  • Environmental Monitoring*
  • Environmental Pollutants / toxicity*
  • Environmental Pollutants / urine*
  • Epidemiological Monitoring
  • Female
  • Health Status
  • Humans
  • Inflammation
  • Insulin Resistance
  • Lipids / blood
  • Liver Diseases / blood
  • Liver Diseases / epidemiology*
  • Liver Diseases / urine
  • Liver Function Tests
  • Male
  • Middle Aged
  • Nutrition Surveys
  • Obesity / blood
  • Obesity / epidemiology
  • Obesity / urine
  • Phenols / toxicity*
  • Phenols / urine*
  • Regression Analysis
  • Respiratory Tract Diseases / blood
  • Respiratory Tract Diseases / epidemiology
  • Respiratory Tract Diseases / urine
  • United States

Substances

  • Benzhydryl Compounds
  • Biomarkers
  • Blood Glucose
  • Environmental Pollutants
  • Lipids
  • Phenols
  • bisphenol A